Tag: Novartis Pharmaceuticals Corporation

Industrial-Academic collaboration: The key for C-H bond activation

Written by
Large-scale manufacturing of medication is only possible with effective synthesis of pharmaceutical ingredients.

A very hot and current scientific topic is the synthesis of active pharmaceutical ingredients (APIs), the burning question being “how can we make API synthesis efficient?”. A big step towards the answer was taken by Dr Guillaume Journot, senior scientist at Servier, France, and Dr Jean-François Brière, a CNRS senior research scientist at COBRA laboratory in Rouen, France. They proved […]

Read More… from Industrial-Academic collaboration: The key for C-H bond activation

Counting the costs of ankylosing spondylitis

Written by

Ankylosing spondylitis (AS) is a chronic rheumatic disease. A debilitating condition, it has large patient and societal burdens. However, the financial impact of the disease is not fully understood. Aiming to change this are Dr Jessica Walsh from the University of Utah School of Medicine, Drs Xue Song and Gilwan Kim from IBM Watson Health, and Dr Yujin Park from Novartis […]

Read More… from Counting the costs of ankylosing spondylitis